This study is to determine whether a medication on the market for other indications is effective and safe in treating seborrheic dermatitis of the face.
To test the efficacy and safety of azelaic acid 15% gel in the treatment of seborrheic dermatitis of the face
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
48
15% gel, topically applied daily for six weeks
placebo, topically applied daily for six weeks
Unnamed facility
Blankenfelde-Mahlow, Germany
Unnamed facility
Buchholz, Germany
Unnamed facility
Hamburg, Germany
Unnamed facility
Hamburg, Germany
Sum Score of the symptoms of seborrheic dermatitis and the investigator's global assessment.
Time frame: Measurement of parameters during the course of treatment (six weeks)
Investigators' and patients' subjective assessment of improvement; frequency and intensity of single symptoms
Time frame: Measurement of parameters during the course of treatment (six weeks)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.